Journal of the European Academy of Dermatology and Venereology

Article	Citations
Issue Information	318
Announcement	207
Editor's Picks January 2024	201
Announcement	168
Commentary on vitiligo patient population and disease burden in France: VIOLIN Study results from the CONSTANCES cohort	156
	138
Pioneers in Dermatology and Venereology: an interview with Professor Sarolta Kárpáti	113
Pioneers in Dermatology and Venereology: an Interview with Professor David M. Pariser	96
Pioneers in Dermatology and Venereology: An Interview with Professor An Goossens	95
Clinical evaluation of anaesthetic‐like effect of two dermocosmetic formulations containing Aquaphilus dolomiae extract‐G3 in subjects with sensitive facial skin	88
Announcement	80
Pioneers in Dermatology and Venereology: An Interview with Professor Danilo V. Stevanovic	80
Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024	78
2013–2023: A decade of progress and challenges in dermatology as reflected in JEADV	77
High prevalence of extracutaneous involvement in ITG junctional epidermolysis bullosa	73
Assessing the efficacy of selective JAK inhibitors for alopecia areata with a patient‐centered approach	73
Two cases of cerebrovascular accidents following the induction dose of risankizumab	71
Disproportionate quality of life decline and unaddressed limitations in amlitelimab atopic dermatitis trial	64
Risk analysis of systemic side effects of tumescent local anaesthesia in the surgical treatment of geriatric and multimorbid patients with skin cancer	63
Hidradenitis suppurativa: One step forward in timely diagnosis and appropriate treatment	60
Are non‐fungible tokens the barrier to realizing the Dermoverse?	57
Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations	55
Pityriasis lichenoides et varioliformis acuta after SARS‐CoV‐2 infection and relapse after vaccination	53
Systemic neurokinin‐1 receptor antagonists mitigate chronic pruritus: A systematic review and meta‐analysis	52
Acrodermatitis chronica atrophicans with clonal light chains and heavy chain rearrangement	50

Genetic susceptibility in early‐onset melanoma: An observational Greek cohort study	49
Barrier function‐related genes and proteins have an altered expression in acne‐involved skin	49
Paradoxical joint and muscle pain in a patient treated with anifrolumab and belimumab	48
Response to ‘Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis: A global cohort study’	48
Detecting T‐cell receptor clonality in patients with severe atopic dermatitis refractory to dupilumab	47
Melanoma in women of childbearing age and in pregnancy in California, 1994–2015: a population‐based cohort study	47
New onset of systemic lupus erythematosus following COVID‐19 mRNA vaccination	46
Intriguing concept of pigmented contact dermatitis: Further understanding the role of hair colours including natural henna	46
Aquagenic pruritus: A web‐based survey study exploring itch characteristics, therapeutic options and patient perspectives	46
Clinical and molecular diagnosis of genodermatoses: Review and perspectives	46
Scar diastasis index: a smart and reproducible tool to evaluate long‐standing scars	45
A new era for alopecia areata: New treatments and improved knowledge of the condition	44
Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event	44
Long‐term patient‐reported perception and experience of methylprednisolone pulse with or without methotrexate in alopecia areata: A French retrospective single‐centre cohort	44
Hand–foot syndrome like eruption following mRNA COVID‐19 vaccine	44
Comment on ‘Negative SARS‐CoV‐2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea‐like eruptions’	43
Impact of menopause on the skin…information still insufficient	42
	41
Issue Information	41
	41
The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of use	40
Contact allergy may enhance further sensitization to new chemicals, but individual susceptibility traits are important for polysensitization	40
Announcement	40
A case of eruptive halo nevi following COVID‐19	39
Comment on ‘Efficacy and tolerance of dupilumab in patients with moderate‐to‐severe atopic dermatitis and obesity’ by Dupuis et al.	39
Dalbavancin for the treatment of severe hidradenitis suppurativa	39
The affliction of job, as painted by Jusepe de Ribera: A dermatological observation going back to the 17th century	39
Juvenile localized scleroderma: A single‐centre experience from India	39
Announcement	39
Genomic and antimicrobial resistance analyses of Neisseria gonorrhoeae isolates, Burkina Faso, 2018–2019	38
Erythema multiforme major associated with molnupiravir treatment for SARS‐CoV‐2 infection: First report	38
The chicken or the egg of lymphopenia in atopic eczema	38
The future of digital pills and their potential use in dermatological clinical trials	38
Automated dermatoscopic pattern discovery by clustering neural network output for human–computer interaction	37
Deep learning predicted perceived age is a reliable approach for analysis of facial ageing: A proof of principle study	37
Pharmacovigilance: The responsibility of all	37
Educational, labour market and relationship outcomes in people with acne	36
Editor’s Picks June 2025	36
Multiple basal cell carcinomas revealing a biallelic MUTYH gene mutation in a 39‐year‐old male patient	36
Rituximab in immunobullous disorders during the COVID‐19 pandemic: A systematic review of observational studies	36
Chat GPT in dermatology: Progressive or problematic?	35
Angiolymphoid hyperplasia with eosinophilia infiltrated by GATA3+ Th2 cells responding to dupilumab	35
Delphi consensus on melasma management by international experts and pigmentary disorders society	35
Comparison of molecular and serological assays on cerebrospinal fluid for the diagnosis of neurosyphilis	35
Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort	34
Application of integrated skincare in medical aesthetics: A literature review	34
Course and outcome of chilblain‐like acral lesions during COVID‐19 pandemic	34
Comparison of performance of SCORTEN, ABCD‐10 and Re‐SCORTEN in a cohort of patients with Stevens–Johnson syndrome/toxic epidermal necrolysis	34
Microinfusion of 5‐fluorouracil using a tattooing machine in keloid treatment	34
Can we trust AI for acne advice: A double‐blind performance comparison with NICE guidelines	34

Efficacy of imiquimod in the management of lentigo maligna	33
Drug survival of alitretinoin treatment for chronic hand eczema: A Danish nationwide cohort study	33
Identification of children at risk for the development of severe paediatric plaque psoriasis: Findings from the prospective observational long‐term Child‐CAPTURE registry	33
Dupilumab for the treatment of refractory allergic contact dermatitis from rubber/latex concomitant with atopic dermatitis	33
Two cases of anti‐TIF1‐γ antibody positive dermatomyositis with manifested symptoms after SARS‐CoV‐19 vaccination	33
Single‐cell RNA‐seq reveals abnormal differentiation of keratinocytes and increased inflammatory differentiated keratinocytes in atopic dermatitis	32
Real‐life efficacy and safety of upadacitinib in adolescents with moderate‐to‐severe atopic dermatitis unresponsive to dupilumab: A case series	32
Global study reveals almost half of patients with skin disease suffer from sleep disturbances and identifies predictive factors	32
A dermocosmetic product containing the sap of oat plantlets and Garcinia mangostana extract improves the clinical signs of acne	32
Epidermal barrier function in dry, flaky and sensitive skin: A narrative review	31
Efficacy and safety of etrasimod in alopecia areata: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 2 study	31
Peer review, scientific publishing and the law of reciprocity	31
Efficacy of long‐term risankizumab treatment for moderate‐to‐severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitl	31
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study	31
Reply to comments by Tadulewicz and Muklewicz on socio‐economic outcomes of atopic dermatitis	30
Editor’s Picks December 2025	30
Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma	30
Urinary incontinence and female genital lichen sclerosus	30
Effectiveness and safety of upadacitinib for moderate‐to‐severe atopic dermatitis in a real‐world setting: A 52‐week retrospective study	30
Biomarkers in rosacea: A systematic review	30
Advances in biologic therapy of psoriasis	29
Skin microbiome and its association with host cofactors in determining atopic dermatitis severity	29
Louis Adolphus Duhring: An enduring legacy	29
Real‐world efficacy and safety of dupilumab in Chinese patients with atopic dermatitis: a single‐centre, prospective, open‐label study	29
Unmet clinical needs and burden of disease in hidradenitis suppurativa: real‐world experience from EU5 and US	29
Effectiveness of secukinumab for the treatment of erythrodermic psoriasis: Multicentre study in daily practice	29
Issue Information	28
Commentary to ‘Development of a patient‐reported experience measure for chronic inflammatory skin diseases’ by E. Van den Steen et al.	28
Announcement	28
	28
Pioneers in Dermatology and Venereology: an interview with Professor Jens‐Michael Schröder	28
	28
Announcement	28
A cross‐sectional study of dermatologists' attitudes towards COVID‐19 vaccination in patients with immunobullous diseases	27
High‐dose intravenous immunoglobulin co‐treatment prolongs time‐to‐treatment escalation in autoimmune bullous diseases: A monocentric retrospective cohort study	27
Schnitzler syndrome associated with recurrent subacute thyroiditis and SARS‐CoV‐2 vaccine—A case review	27
	27
A case of advanced diffuse large B‐cell lymphoma diagnosed from widespread superficial mycosis of the skin	27
Pioneers in Dermatology and Venereology: An interview with Professor Gil Yosipovitch	27
Heterologous versus homologous primary and booster COVID‐19 vaccination do not increase flare rate in patients with psoriasis and/or psoriatic arthritis: Insights from a real‐life, multicen	27
Evidence for no genetic causal association between skin response to sun exposure and systemic lupus erythematosus: A Mendelian randomization study in Europeans and East Asians	26
Association of hidradenitis suppurativa and malignancy: A systematic review and meta‐analysis	26
Evidence for differing roles of CD11c+CD163+ and CD11c−CD163+ cells in intracellular pigment storing in tattoos and stasis	26
Delay in the diagnosis and management of suspicious malignant skin lesions during the COVID‐19 pandemic in a reference centre in Mexico	26
Morphoea en coup de sabre with Adie's pupil: An exceptional association	26
Comment on “Psoriasis may increase the risk of lung cancer: A two‐sample Mendelian randomization study”	26
Comparison of artificial intelligence smartphone applications for skin cancer risk stratification of pigmented lesions: An observational study	26
Drug reaction with eosinophilia and systemic symptoms in a 10‐year‐old boy sparing lichen planus lesions: an example of reverse isotopic response	26
Female genital mucosal lesions associated with COVID‐19 vaccination: A brief review of the literature	25
Dermoscopic image colour correction based on gamma correction and multi‐scale image fusion	25
Effects of bariatric surgery on severe suppurative hidradenitis: Results of a nationwide administrative data study in France	25
Severity strata and minimally important differences of CompAQ and Skindex‐16 for patients with acne	25
Deciphering differential response to NB‐UVB: The hair matters	25
Erectile dysfunction in patients with seborrhoeic dermatitis	24
Comparison of the burden of pruritus and pain: Analysis of survey data from 4018 subjects	24
Announcement	24
Diagnosis and treatment of nail melanoma: a review of the clinicopathologic, dermoscopic, and genetic characteristics	24
A special thank you to our reviewers!	24
	24
	24
Announcement	24
Modest psoriasis risk from cardiometabolic progression: Genetics, patterns and limitations in a Biobank study	24
Long‐term effects of the COVID‐19 pandemic on malignant melanoma: increased lymph node metastases in two German dermatology clinics	24
Timing, age and immune profiling refine strategy in lichenoid chronic GVHD – Authors' reply	24
	24
Scabies revisited in the COVID‐19 era	23
Beta‐blockers efficacy and safety in the treatment of PHACE syndrome: A systematic review	23
Serial dermoscopic monitoring of subungual scabies mites in an infant with crusted scabies	23
Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patients	23
AI‐assisted basal cell carcinoma diagnosis with LC‐OCT: A multicentric retrospective study	23
Nail psoriasis: a rare mRNA COVID‐19 vaccine reaction	23
Dermatitis herpetiformis triggered by iodine contrast media	23
Hair transplantation in folliculitis decalvans: Outcome description in a multicentre series of 11 patients	23
Long‐term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3b trial	23
The Prurigo Control Test reflects the severity of itch and skin lesions in patients with chronic prurigo: Data from a real‐world study	23
Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of PREG‐CU, a UCARE study	23
Association of dermoscopic signs of regression in melanocytic lesions with immune checkpoint inhibitor response in metastatic melanoma patients	23
Beyond the surface: Integrating sex and gender in dermatologic therapy	22
Is risankizumab as needed administration a good option for patients with plaque psoriasis?	22
Low‐dose oral minoxidil in female patients with lichen planopilaris: Real‐life experience	22

Burnout among French dermatologists: A national study	22
Atopic dermatitis exacerbation after Covid‐19 vaccination in Dupilumab‐treated patients	22
High‐frequency ultrasound accuracy in preoperative cutaneous melanoma assessment: A meta‐analysis	22
Paediatric mycosis fungoides – characteristics, management and outcomes with particular focus on the folliculotropic variant	22
Scabies treatment with benzyl benzoate in patients younger than 2 years: A single‐centre experience	22
Response to Letter to the Editor—Assessing UWB‐RSOM for non‐invasive melanoma depth: Diagnostic potential and critical limitations	22
Outcome and long‐term treatment protocol for topical tacrolimus in oral lichen planus	22
Chronic pruritus in multiple sclerosis and clinical correlates	22
Rifampicin and clindamycin for epidermal growth factor receptor inhibitor‐related acneiform rash	22
A case of Anti‐MDA5‐Positive dermatomyositis after inactivated COVID‐19 vaccine	22
New regulation of medical devices in the EU: impact in dermatology	22
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16‐week multicentre retrospective study	22
Assessment of metabolic dysfunction‐associated steatotic liver disease in patients with hidradenitis suppurativa: A cross‐sectional study	22
Differing features of pemphigus in skin of colour versus white skin: A broad‐scale cohort study	21
Real‐world experience of switching from tralokinumab to lebrikizumab in atopic dermatitis	21
Efficacy and safety of nemolizumab in paediatric atopic dermatitis: A 24‐week real‐world case series	21
Risk of de novo bullous pemphigoid and pemphigus following transplantation: A global wide‐scale cohort study	21
Response to ‘Dupilumab: No elevated maternal risks in propensity‐matched cohort’ by Preuß et al.	21
Stevens‐Johnson syndrome induced by Vaxvetria (AZD1222) COVID‐19 vaccine	21
Upadacitinib in dermatology: ‘Killing’ several diseases with one stone	21
Scratching the surface: NK‐1 inhibitors for chronic itch—Promise or placebo?	21
Dutasteride intralesional microinjections in combination with oral minoxidil vs. oral minoxidil monotherapy in men with androgenetic alopecia: a retrospective analysis of 105 patients	21
Ambassadors in Dermatology and Venereology: An interview with Professor Andreas Katsambas	21
Evaluation of risk in chronic cutaneous inflammatory conditions for malignant transformation	21
2021 European guideline on the management of Mycoplasma genitalium infections	21
Incidence and remission rates of self‐reported hidradenitis suppurativa ‐ A prospective cohort study conducted in Danish blood donors	21
From COVID‐19 to war – life of a dermatological journal in times of crisis	20
Haematopoietic stem cell transplant in cutaneous T‐cell lymphomas: A multicentre propensity‐score matched study	20
Delayed hypersensitivity of hyaluronidase: a case report	20
Health‐related quality of life during different stages of decongestive therapy on patients with lymphoedema of the legs	20
Announcement	20
False negative RPR test with prozone phenomenon in an HIV‐negative man with secondary syphilis	20
Drug survival of adalimumab biosimilar vs adalimumab originator in hidradenitis suppurativa: Can equivalence be assumed? A retrospective cohort study	20
Impact of COVID‐19 in patients with autoimmune bullous diseases: Report from an international registry	20
The watch sign: an atypical clinical finding of frontal fibrosing alopecia in two male patients	20
Pioneers in Dermatology and Venereology: An interview with Professor Johannes Ring	20
Prevalence of hirsutism in Turkey: Data of the dermatoendocrinology study group	20
Netherton syndrome and papillomatous lesions—Should we perform human papilloma virus vaccination?	20
Fears, concerns and expectations in dermatologic emergencies: A qualitative and descriptive study in a tertiary hospital	19
Transcriptomic analysis of one patient with lupus skin lesions treated with anifrolumab	19
Infantile scabies misdiagnosed and treated as Langerhans cell histiocytosis: A case report	19
Advances in image‐based diagnosis of nail disorders	19
Granular parakeratosis	19
Neuropathy as an early warning sign of desmoplastic neurotropic melanoma of the head	19
Culture‐based analyses of skin bacteria in lesional moist, and unaffected dry and sebaceous skin regions of hidradenitis suppurativa patients	19
Thirty years of promoting sun safety in France: The messages are heard but not followed!	19
A rare case of agminated juvenile Xanthogranuloma: Clinical and dermatoscopic evolution	19
The tumour triangle – A symbol‐based mnemonic for teaching important clinical characteristics of skin cancer	19
Reactive nonsexually related acute genital ulcers: A retrospective analysis of the Mayo Clinic experience	19
Premature skin ageing signs due to androgen deprivation therapy	19
Cyclic photodynamic therapy delays first onset of actinic keratoses in renal transplant recipients: a 5‐year randomized controlled trial with 12‐month follow‐up	19
Dysregulation of epigenetic, biological and mitotic age in the context of biologic drug treatment and phototherapy in plaque psoriasis patients	19
Correction to ‘Classification of psychodermatological disorders: Proposal of a new international classification’	19
Nonsense mutations in KRT1 caused recessive epidermolytic palmoplantar keratoderma with knuckle pads	19
Study on hair root lipids of female androgenetic alopecia based on UPLC‐Q‐TOF/MS results	19
Concordance of in vivo reflectance confocal microscopy and horizontal‐sectioning histology in skin tumours	19
Racial representation in dermatology clinical trials, a Canadian perspective	19
Non‐invasive, in vivo, characterization of cutaneous metastases using a novel multimodal RCM‐OCT imaging device: a case‐series	19
Issue Information	19
Beremagene geperpavec (B‐VEC) for infantile dystrophic epidermolysis bullosa: Benefit of early intervention	19
Purtscher‐like retinopathy after hyaluronic filler injection for facial augmentation	19
A prospective, multicentre study to assess frailty in elderly patients with leg ulcers (GERASstudy)	19
Improvement of redness and hyperkeratosis in a case of Nagashima‐type palmoplantar keratosis during Tofacitinib treatment for ulcerative colitis	19
Store‐and‐forward mobile application as an accessible method of study participant assessment	19
Dupilumab treatment for severe atopic dermatitis in children and SARS‐CoV‐2 infection: A combination of triggers for psoriasis	19
A 5‐year retrospective cohort study of basal cell carcinomas on the head and neck: Anatomic location as a predictor of subclinical tumour extension	19
Alopecia associated with the use of semaglutide and tirzepatide: A disproportionality analysis using the FDA adverse event reporting system (FAERS) from 2022 to 2023	18
Reply to ‘Nail psoriasis: A rare mRNA COVID‐19 vaccine reaction’ by Lamberti A et al.	18
Merkel cell carcinoma from renal transplant recipients are mostly MCPyV‐negative and are frequently associated with squamous cell carcinomas or precursors	18
Hidradenitis suppurativa: A prospective epidemiologic study in Albania	18
Number of melanoma deaths over time in relation to tumour thickness: Data from a Melanoma Unit Reference Center	18
	18
Lentigo maligna: A retrospective analysis of 50 cases treated with imiquimod monitored with non‐invasive reflectance confocal microscopy	18
The effect of abnormal secretion of DKK1 by fibroblasts on melanocytes function in vitiligo	18
Utility of ruxolitinib in a patient with chronic mucocutaneous candidiasis caused by STAT1 gain‐of‐function mutation	18
Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient‐Oriented Outcomes and Urticaria and Angio	18
Risk of adverse events of psoriasis treatment with biologic agents and new small molecules—BIOBADADERM Registry	18
Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study	18
Announcement	18
Probing into functional decline among bullous pemphigoid patients	18
Dual impact of smoking cessation and post‐cessation weight change on psoriasis	17
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate‐to‐severe atopic dermatitis: A nationwide retrospective cohort study	17
Analysis of the structure and function of the epidermal barrier in patients with ichthyoses—clinical and electron microscopical investigations	17
Tinea nigra with dermoscopic diagnosis: First autochthonous case in Italy?	17
Cryosurgery versus curettage for intraepidermal carcinoma: A randomized controlled trial	17
Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial	17
A novel and effective therapy for Zoon balanitis: Topical crisaborole 2% ointment	17
Stigmatizing attitudes towards facial psoriasis, atopic dermatitis, vitiligo and alopecia areata	17
Unveiling the true costs and societal impacts of moderate‐to‐severe atopic dermatitis in Europe	17
Trichophyton mentagrophytesITS genotype VII infections among men who have sex with men in France: An ongoing phenomenon	17
A deep‐learning algorithm to localize basal cell carcinoma foci on Mohs surgery frozen sections	17
Risk score stratification of cutaneous melanoma patients based on whole slide images analysis by deep learning	17
Efficacy, safety and patient's satisfaction for treatment of genital psoriasis with tildrakizumab: a case series and review of literature	17
Merkel cell carcinoma after solid organ transplant	17
The spectrum of skin disease in VEXAS syndrome: a report of a novel clinico‐histopathologic presentation	17